Alpine Immune Sciences Inc's Suppliers recorded an increase in sales by 2.25 % year on year in Q1 2024, from the previous quarter, sales fell by -35.89 %, while their net margin rose to 20.71 % year on year, Alpine Immune Sciences Inc's Suppliers improved sequentially profit margin to -35.89 %,
Alpine Immune Sciences Inc's Suppliers recorded an increase in sales by 2.25 % year on year in Q1 2024, from the previous quarter, sales fell by -35.89 %, while their net margin rose to 20.71 % year on year, Alpine Immune Sciences Inc's Suppliers improved sequentially profit margin to 20.71 %,
Alpine Immune Sciences Inc's Comment on Supply Chain
The company employs contract manufacturers specializing in protein production, analytical development, and fill/finish to support rapid timelines from production cell-line development to clinical trial manufacturing. It has completed two cGMP drug substance manufacturing campaigns for acazicolcept and two for povetacicept, producing quantities sufficient for the Synergy and RUBY clinical trials. A commercial-scale manufacturing process for povetacicept has been established, with plans for manufacturers to supply material for late-phase clinical studies.
Alpine Immune Sciences Inc's Comment on Supply Chain
The company employs contract manufacturers specializing in protein production, analytical development, and fill/finish to support rapid timelines from production cell-line development to clinical trial manufacturing. It has completed two cGMP drug substance manufacturing campaigns for acazicolcept and two for povetacicept, producing quantities sufficient for the Synergy and RUBY clinical trials. A commercial-scale manufacturing process for povetacicept has been established, with plans for manufacturers to supply material for late-phase clinical studies.
ALPN's Suppliers Net Income grew by
ALPN's Suppliers Net margin grew in Q1 to
9.57 %
20.71 %
ALPN's Suppliers Net Income grew by 9.57 %
ALPN's Suppliers Net margin grew in Q1 to 20.71 %
Alpine Immune Sciences Inc's Suppliers Sales Growth
in Q1 2024 by Industry
Sources:
Alpine Immune Sciences Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Alpine Immune Sciences Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
28.21 %